Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185 | 532 | 788 | 67 | 286 |
| Receivables | 76 | 75 | 1,907 | 45 | 54 |
| Inventories | 123 | 94 | 40 | N/A | 488 |
| Other current assets | 0 | 0 | 106 | 26 | 0 |
| TOTAL | $385 | $704 | $2,841 | $156 | $851 |
| Non-Current Assets | |||||
| PPE Net | 62 | 129 | 123 | 158 | 454 |
| Intangibles | 0 | 0 | 0 | 0 | 471 |
| TOTAL | $62 | $129 | $123 | $158 | $925 |
| Total Assets | $447 | $833 | $2,964 | $314 | $1,777 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 66 | 85 | 563 | 172 | 1,000 |
| Accrued Expenses | 117 | 135 | 339 | 351 | 466 |
| TOTAL | $211 | $220 | $1,608 | $868 | $1,466 |
| Non-Current Liabilities | |||||
| Long Term Debt | 198 | N/A | N/A | N/A | N/A |
| TOTAL | $198 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $409 | $220 | $1,608 | $868 | $1,466 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 886 | 886 | 886 | 886 | 886 |
| Common Shares | 12 | 12 | 12 | 12 | 12 |
| Retained earnings | -40,682 | -40,063 | -39,320 | -37,495 | -37,711 |
| Other shareholders' equity | -31 | 0 | 0 | -1,434 | 0 |
| TOTAL | $39 | $613 | $1,356 | $-554 | $311 |
| Total Liabilities And Equity | $447 | $833 | $2,964 | $314 | $1,777 |